Skip to content

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Find out more here. Hide this message

Membership Matters

Trust introduces new physician associate role

In October the Trust will welcome 11 new physician associates (PAs), who will complete four six-month rotations as part of a two-year preceptorship programme.

Physician associates are medically trained, generalist healthcare professionals who will work alongside doctors and provide medical care as an integral part of a multidisciplinary team. While trainee doctors and surgeons rotate through different specialties, physician associates will offer continuity and stability both for patients and for the team in which they work. Physician associate support will also provide cover so that trainee doctors can attend training, clinic or theatre.

Physician associates' ability to practise medicine will be enabled by collaboration and supportive working relationships with their clinical and educational supervisors - meaning that there is always someone who can discuss cases, give advice and attend to patients if necessary.

The PA role is important as it will complement the numbers of the medical workforce and increase access to quality care for patients. PAs will act in an enabling role, helping to reduce a healthcare team’s workload and bring new talent to the NHS, adding to the skill mix within the teams.

A receptionist at an information stand reading some paperwork

Your Visit

Two female receptionists on the phone at a desk smiling

Feedback

Chinese Poland

View all languages >

Visiting update

To protect our patients, staff, visitors and the community, we are again restricting visitors to all our hospitals sites so please read our latest guidance for full details before coming to our hospitals.

The decision to restrict visitors during this time has been very difficult and made only after careful consideration as we witness wider social restrictions to prevent the spread of COVID-19 in light of the highly transmissible OMICRON variant.  The guidance will be reviewed regularly.